Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-06-09 Sale |
2023-06-09 7:00 pm |
Krystal Biotech Inc. | KRYS | ORTH ANDREW C. Chief Commercial Officer |
12,500 | $128.61 | $1,607,635 | 37,600 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-06-09 Exercise |
2023-06-09 7:00 pm |
N/A 2032-02-27 |
Krystal Biotech Inc. | KRYS | ORTH ANDREW C. Chief Commercial Officer |
12,500 | $0 | 37,600 (Direct) |
View |
| 2023-06-09 Exercise |
2023-06-09 7:00 pm |
N/A N/A |
Krystal Biotech Inc. | KRYS | ORTH ANDREW C. Chief Commercial Officer |
12,500 | $63.55 | 37,600 (Direct) |
View |
| 2023-02-28 Option Award |
2023-02-28 6:45 pm |
N/A 2033-02-28 |
Krystal Biotech Inc. | KRYS | ORTH ANDREW C. Chief Commercial Officer |
30,000 | $0 | 30,100 (Direct) |
View |
| 2022-02-28 Option Award |
2022-03-01 9:22 pm |
N/A 2032-02-28 |
Krystal Biotech Inc. | KRYS | ORTH ANDREW C. Chief Commercial Officer |
50,000 | $0 | 50,100 (Direct) |
View |
| 2021-05-31 Option Award |
2021-06-02 7:19 pm |
N/A 2031-05-31 |
Krystal Biotech Inc. | KRYS | ORTH ANDREW C. Chief Commercial Officer |
205,000 | $0 | 205,100 (Direct) |
View |
Ownership |
2021-05-11 7:31 pm |
N/A N/A |
Krystal Biotech Inc. | KRYS | ORTH ANDREW C. Chief Commercial Officer |
0 | $0 | 100 (Direct) |
View |